The University of Texas MD Anderson Cancer Center
Department of Gynecologic Oncology and Reproductive Medicine

 The objective of Dr. Jazaeri’s research program is to develop more effective immunotherapy treatments for patients with gynecologic cancers. This is achieved through a number of investigator initiated translation-rich clinical trials aimed at understanding immunologic barriers to response and rational combination therapies.  Dr. Jazaeri also leads the Industry Alliance with Iovance aimed at testing adoptive cell therapy with Tumor Infiltrating Lymphocytes across multiple solid tumors.  Lastly, Dr. Jazaeri co-leads the Ovarian SPORE Project 3 with Dr. Bast aimed at testing the safety and efficacy of SIK2 inhibition in ovarian cancer.

PubMed

MDACC Faculty

Education & Training

MD, University of Virginia School of Medicine, 1996

Programs

• Immunology

---